Filter
1010
Filtered Results: 1010
Text search:
sérologie
Featured
Recommendations
123
New Publications
267
Language
Document type
No document type
514
Guidelines
261
Studies & Reports
111
Manuals
47
Fact sheets
34
Strategic & Response Plan
26
Situation Updates
7
Infographics
5
Training Material
3
Brochures
1
Resource Platforms
1
Countries / Regions
Global
37
Germany
35
Latin America and the Carribbean
32
India
32
Africa
23
Colombia
20
South Africa
20
Western and Central Europe
19
Nigeria
18
Congo, Democratic Republic of
17
Philippines
16
Senegal
15
Bangladesh
15
Paraguay
14
Argentina
14
Ethiopia
13
Nepal
10
Mozambique
10
West and Central Africa
10
Bolivia
10
Indonesia
10
Kenya
9
Sierra Leone
9
Rwanda
9
Burkina Faso
9
Peru
9
Venezuela
9
Tanzania
9
East and Southern Africa
9
Brazil
9
Central African Republic
9
Guinea
8
Zambia
8
Uganda
7
Haiti
6
Eastern Europe
6
Madagascar
6
Ukraine
5
Benin
5
Cameroon
5
Malawi
5
Middle East and North Africa
5
Russia
5
Liberia
5
Myanmar / Burma
5
Lesotho
4
Ghana
4
Syria
4
Asia
4
South–East Asia Region
4
France
4
Spain
4
Angola
4
Ecuador
4
Pakistan
4
China
3
Afghanistan
3
USA
3
Cambodia
3
Côte d’Ivoire / Ivory Coast
3
Vietnam
3
Namibia
3
North Macedonia
2
Mexico
2
El Salvador
2
Turkey
2
Iran
2
Albania
2
Zimbabwe
2
Jordan
2
Saudi Arabia
2
Eastern Europe and Central Asia
2
Portugal
2
Lebanon
2
Egypt
2
Sudan
2
Mali
2
South Sudan
2
Iraq
2
Tajikistan
1
Togo
1
Chile
1
Laos
1
Morocco
1
Qatar
1
Italy
1
Guinea-Bissau
1
Tunisia
1
United Kingdom
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Chad
1
Libya
1
Bhutan
1
Botswana
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
397
Clinical Guidelines
160
Pharmacy & Technologies
45
Public Health
27
Women & Child Health
19
Key Resources
15
Capacity Building
5
Toolboxes
COVID-19
155
NTDs
112
HIV
97
Rapid Response
83
Zika
56
TB
48
Ebola
39
Refugee
23
AMR
14
Planetary Health
13
Pharmacy
13
Caregiver
10
Mental Health
9
Cholera
8
Polio
8
Natural Hazards
3
Global Health Education
3
Disability
2
NCDs
2
Conflict
2
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
Leishmaniose cutanée : un important problèmede santé
La leishmaniose cutanée est une maladie potentiellement grave et défigurante. Les personnes atteintes de leishmaniose cutanée ont une ou plusieurs lésions durables sur la peau, le plus souvent sans fièvre ni symptômes généraux. L'impac...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
